Bio-Images Drug Delivery: Funding, Investors & Team (Sep 2026)
BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing. Our patented time release technology OralogiK provides unrivaled control of drug release at the right place and time. OralogiK has been validated in numerous clinical studies, enables the oral delivery of single, multi-dose or combination drugs at pre-determined times between one and 12 hours after being swallowed by the patient. This facilitates such benefits as: night time dosing of a drug to be delivered pre-wakeup multi-phased delivery of one or more drugs (immediate and delayed) to allow once-a-day dosing or for pre-treatment by one drug before the delivery of a second delivery of drugs to a specific regions of the digestive system (e.g. the colon) BDD also specialize in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
Bio-Images Drug Delivery has raised $1.2M across 1 funding round on record, the most recent an undisclosed round of $1.2M announced in Dec 2020.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bio-Images Drug Delivery Company Profile and Key Stats
Latest funding round on record: Dec 2020.
Bio-Images Drug Delivery Funding Rounds
Bio-Images Drug Delivery Founders and Leadership Team
Contact details for the Bio-Images Drug Delivery team: 1 of 1 has an email address on file.
Start 14-day free trial →Bio-Images Drug Delivery Funding Compared to Other Biotechnology Startups
Bio-Images Drug Delivery's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bio-Images Drug Delivery in Biotechnology and Glasgow
Companies Similar to Bio-Images Drug Delivery
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Bio-Images Drug Delivery Funding FAQs
What does Bio-Images Drug Delivery do?
BDD is a specialist drug formulation company providing expertise across all areas of drug delivery. We offer a full service package to fit individual needs from troubleshooting, formulation development, in vitro and in vivo testing. Our patented time release technology OralogiK provides unrivaled control of drug release at the right place and time. OralogiK has been validated in numerous clinical studies, enables the oral delivery of single, multi-dose or combination drugs at pre-determined times between one and 12 hours after being swallowed by the patient. This facilitates such benefits as: night time dosing of a drug to be delivered pre-wakeup multi-phased delivery of one or more drugs (immediate and delayed) to allow once-a-day dosing or for pre-treatment by one drug before the delivery of a second delivery of drugs to a specific regions of the digestive system (e.g. the colon) BDD also specialize in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report.
How much funding has Bio-Images Drug Delivery raised?
Bio-Images Drug Delivery has raised $1.2M across 1 round on record. The most recent is an undisclosed round of $1.2M announced in Dec 2020.
When did Bio-Images Drug Delivery last raise funding?
Bio-Images Drug Delivery's most recent funding round on record is an undisclosed round of $1.2M, announced in Dec 2020.
Who is the CEO of Bio-Images Drug Delivery?
Carol Thomson is listed as CEO at Bio-Images Drug Delivery.
Where is Bio-Images Drug Delivery headquartered?
Bio-Images Drug Delivery is based in Glasgow, United Kingdom.
How many employees does Bio-Images Drug Delivery have?
Bio-Images Drug Delivery is in the 11-50 employee band.
How does Bio-Images Drug Delivery's funding compare to other Biotechnology startups?
Bio-Images Drug Delivery's latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Bio-Images Drug Delivery Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bio-Images Drug Delivery is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.